Axa S.A. Regenxbio Inc. Transaction History

Axa S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$42.0 - $59.29 $239,400 - $337,953	-5,700 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $1.16 Million - $1.77 Million	-28,400 Reduced 83.28%	5,700 $327,000
Q4 2018 Feb 13, 2019	BUY	$39.11 - $75.15 $793,933 - $1.53 Million	20,300 Added 147.1%	34,100 $1.43 Million
Q3 2018 Nov 08, 2018	BUY	$65.0 - $82.15 $708,500 - $895,435	10,900 Added 375.86%	13,800 $1.04 Million
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $78,880 - $215,614	2,900 New	2,900 $208,000

191

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $492M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.